Chronic cellular hypoxia as the prime cause of cancer: what is the de-oxygenating role of adulterated and improper ratios of polyunsaturated fatty acids when incorporated into cell membranes?

With the exception of melanoma and non-Hodgkin's lymphoma, the incidence of cancer has peaked in the last several years, but rates and mortality are still high. Moreover, despite 50 years of intensive cancer research increasingly focused on genetic causes, no single unifying cause for cancer has been established. Although it is well-known that tumors are hypoxic, and that there is a correlation between the level of hypoxia and prognosis, with the exception of Warburg's studies, little work has been done to investigate the relationship between hypoxia and cancer. Over 70 years ago, Warburg showed that cells could always be made cancerous by subjecting them to periods of hypoxia. Moreover, he demonstrated that once cells had converted to a cancerous state, reversion could not occur. Modern biochemistry acknowledges that there is a switch from oxidative phosphorylation to glycolysis in tumors that might be concurrent with hypoxia, but does not address the cancer causation. It is our hypothesis that long-term hypoxia of cells in the body, measured in years, is the primary trigger for cancer. We believe that the hypoxia, which has to meet Warburg's findings of a critical 35% reduction in intracellular oxygen levels to initiate cancer, is linked to the incorporation of adulterated, non-oxygenating, or inappropriate polyunsaturated fatty acids (PUFAs) into the phospholipids of cell and mitochondrial membranes. Such incorporation causes changes in membrane properties that impair oxygen transmission into the cell. Trans fats, partially oxidized PUFA entities, and inappropriate omega-6:omega-3 ratios are all potential sources of unsaturated fatty acids that can disrupt the normal membrane structure. In this paper, we explore this hypothesis by examining the evidence, and additionally propose an appropriate PUFA dosage for humans by analyzing requirements and taking into account current PUFA consumption patterns.

[1]  C. Léger,et al.  Evidence for a structurally specific role of essential polyunsaturated fatty acids depending on their peculiar double-bond distribution in biomembranes. , 1990, Biochemistry.

[2]  C. Burns,et al.  Effects of lipids on cancer therapy. , 2009, Nutrition reviews.

[3]  I. Campbell,et al.  Abnormal fatty acid composition and impaired oxygen supply in cystic fibrosis patients. , 1976, Pediatrics.

[4]  D. Rakheja,et al.  Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. , 2005, Medical hypotheses.

[5]  T. Galeotti,et al.  Lipid Peroxidation in Cancer Cells: Chemical and Physical Studies a , 1988, Annals of the New York Academy of Sciences.

[6]  A. Sinclair,et al.  Increased alpha-linolenic acid intake increases tissue alpha-linolenic acid content and apparent oxidation with little effect on tissue docosahexaenoic acid in the guinea pig. , 2000, Lipids.

[7]  H. P. Rusch,et al.  Effect of Diet on Tumors Induced by Ultraviolet Light , 1939 .

[8]  K. Garber Energy boost: the Warburg effect returns in a new theory of cancer. , 2004, Journal of the National Cancer Institute.

[9]  Bruce Klitzman,et al.  Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. , 2006, Cancer research.

[10]  O. Warburg On the origin of cancer cells. , 1956, Science.

[11]  Spector Aa,et al.  Biological and therapeutic potential of membrane lipid modification in tumors. , 1987 .

[12]  J. Stanford,et al.  The association of fatty acids with prostate cancer risk , 2001, The Prostate.

[13]  K. Hayes,et al.  Dietary trans-monounsaturated fatty acids negatively impact plasma lipids in humans: critical review of the evidence. , 1996, Journal of the American College of Nutrition.

[14]  N. Heerema,et al.  Precancerous Stem Cells Have the Potential for both Benign and Malignant Differentiation , 2006, PloS one.

[15]  R. Weinberg One Renegade Cell: How Cancer Begins , 1998 .

[16]  K. Bjerve,et al.  Linseed and cod liver oil induce rapid growth in a 7-year-old girl with N-3- fatty acid deficiency. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[17]  R. Schulte‐Hermann,et al.  Induction of lipid peroxidation in biomembranes by dietary oil components. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  G. Klein,et al.  Suppression of Malignancy by Cell Fusion , 1969, Nature.

[19]  A. A. Spector,et al.  Membrane fatty acid modification in tumor cells: A potential therapeutic adjunct , 1987, Lipids.

[20]  M. Mcentee,et al.  Highly Unsaturated (n-3) Fatty Acids, but Not α-Linolenic, Conjugated Linoleic or γ-Linolenic Acids, Reduce Tumorigenesis in ApcMin/+ Mice , 2000 .

[21]  G. Steel,et al.  Basic clinical radiobiology for radiation oncologists , 1993 .

[22]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  B J Krause,et al.  PET and PET/CT studies of tumor tissue oxygenation. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[24]  Duo Li,et al.  What is the role of alpha-linolenic acid for mammals? , 2002, Lipids.

[25]  C. Culmsee,et al.  Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway , 2007, Oncogene.

[26]  R. Mason,et al.  Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. , 2007, International journal of radiation oncology, biology, physics.

[27]  A. Giatromanolaki,et al.  Cancer vascularization: implications in radiotherapy? , 2000, International journal of radiation oncology, biology, physics.

[28]  R. Dhir,et al.  Prostate Tumor Growth and Recurrence Can Be Modulated by the ω-6:ω-3 Ratio in Diet: Athymic Mouse Xenograft Model Simulating Radical Prostatectomy , 2006 .

[29]  Luzhe Sun,et al.  Dietary omega-3 fatty acids and ionizing irradiation on human breast cancer xenograft growth and angiogenesis , 2005, Cancer Cell International.

[30]  S. Silva,et al.  Dietary deficiency or enrichment of essential fatty acids modulates tumorigenesis in the whole body of cobalt-60-irradiated mice. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[31]  R. Dhir,et al.  Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. , 2006, Neoplasia.

[32]  E. Berry Who's afraid of n-6 polyunsaturated fatty acids? Methodological considerations for assessing whether they are harmful. , 2001, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[33]  Duo Li,et al.  What is the role of α-linolenic acid for mammals? , 2002, Lipids.

[34]  R. Holman,et al.  A case of human linolenic acid deficiency involving neurological abnormalities. , 1982, The American journal of clinical nutrition.

[35]  H. Sinclair Essential fatty acids in perspective. , 1984, Human nutrition. Clinical nutrition.

[36]  K K Carroll,et al.  Experimental evidence of dietary factors and hormone-dependent cancers. , 1975, Cancer research.

[37]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[38]  A. Sinclair,et al.  Increased α-linolenic acid intake increases tissue α-linolenic acid content and apparent oxidation with little effect on tissue docosahexaenoic acid in the guinea pig , 2000, Lipids.

[39]  M. Walz,et al.  Does enteral nutrition of dietary polyunsaturated fatty acids promote oxidative stress and tumour growth in ductal pancreatic cancer? Experimental trial in Syrian Hamster. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[40]  Sinclair Hm Essential fatty acids in perspective. , 1984 .

[41]  P. Galan,et al.  Dietary intakes and food sources of n−6 and n−3 PUFA in french adult men and women , 2004, Lipids.

[42]  A. Majeed,et al.  Trends in testicular carcinoma in England and Wales, 1971–99 , 2001, BJU international.

[43]  Berry Em Who's afraid of n-6 polyunsaturated fatty acids? Methodological considerations for assessing whether they are harmful. , 2001 .

[44]  C C Ling,et al.  Repair of radiation induced damage--dependence on oxygen and energy status. , 1988, International journal of radiation oncology, biology, physics.

[45]  A. Igal,et al.  Dietary n-3 fatty acids influence the lipid composition and physical properties of liver microsomal membranes in diabetic rats. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[46]  O. Warburg,et al.  The Metabolism of Carcinoma Cells , 1925 .

[47]  W. Lands,et al.  Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues , 1990, Lipids.

[48]  A. Lanier,et al.  Cancer incidence in Alaska Natives thirty-year report 1969-1998. , 2001, Alaska medicine.

[49]  J. Potter,et al.  Trans-Fatty Acids and Colon Cancer , 2001, Nutrition and cancer.

[50]  Julian P T Higgins,et al.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review , 2006, BMJ : British Medical Journal.

[51]  N. Al-Waili,et al.  Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[52]  M. Dewhirst,et al.  Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[53]  A. A. Spector,et al.  Biological and therapeutic potential of membrane lipid modification in tumors. , 1987, Cancer research.

[54]  H Kesteloot,et al.  Intake of fatty acids in Western Europe with emphasis on trans fatty acids: The TRANSFAIR study , 1999, European Journal of Clinical Nutrition.

[55]  R. A. Malmgren,et al.  Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. , 1955, Cancer research.

[56]  H. Goldblatt,et al.  INDUCED MALIGNANCY IN CELLS FROM RAT MYOCARDIUM SUBJECTED TO INTERMITTENT ANAEROBIOSIS DURING LONG PROPAGATION IN VITRO , 1953, The Journal of experimental medicine.

[57]  R. Dhir,et al.  The yin and yang of 15-lipoxygenase-1 and delta-desaturases: Dietary omega-6 linoleic acid metabolic pathway in prostate , 2006, Journal of carcinogenesis.

[58]  C. Ip,et al.  Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. , 1997, The American journal of clinical nutrition.

[59]  A A Spector,et al.  Membrane lipid composition and cellular function. , 1985, Journal of lipid research.

[60]  J. Booyens,et al.  The Eskimo diet. Prophylactic effects ascribed to the balanced presence of natural cis unsaturated fatty acids and to the absence of unnatural trans and cis isomers of unsaturated fatty acids. , 1986, Medical hypotheses.

[61]  B. Chance,et al.  Some Patterns of the Respiratory Pigments of Ascites Tumors of Mice. , 1952, Science.

[62]  M. Puertollano,et al.  Polyunsaturated fatty acids induce cell death in YAC-1 lymphoma by a caspase-3-independent mechanism. , 2003, Anticancer research.

[63]  B. Chance Was Warburg right? Or was it that simple? , 2005, Cancer biology & therapy.

[64]  M. Simon,et al.  Hypoxia-inducible factors: central regulators of the tumor phenotype. , 2007, Current opinion in genetics & development.

[65]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[66]  J. Fraumeni,et al.  Cancer surveillance series: changing geographic patterns of lung cancer mortality in the United States, 1950 through 1994. , 1999, Journal of the National Cancer Institute.